BACKGROUND/AIMS A new real time monitoring system has been developed to locate the fixation point during juxtafoveal laser photocoagulation.
METHOD The red diode laser beam is combined coaxially with the illumination beam to image a cross in the focal plane of the slit lamp, which allows projection of a red cross onto the patient's fundus. 27 patients with juxtafoveal choroidal neovascularisation were treated by photocoagulation using this system.
RESULTS 13 (48%) patients whose visual acuity ranged from 20/200 to 20/40 answered that it was easier to keep the focus on the cross target image than on the aiming beam. The patient maintained stable fixation throughout the treatment. The laser treatment was completed without foveal damage near the fixation point in all patients.
CONCLUSION The real time fixation monitoring system should allow surgeons to treat juxtafoveal lesions with laser photocoagulation more safely and accurately.
- fixation point monitoring system
- juxtafoveal neovascularisation
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Laser photocoagulation is a beneficial treatment for patients with juxtafoveal choroidal neovascularisation (CNV) resulting from age related macular degeneration.1 To treat juxtafoveal neovascularisation, laser burns should be applied to the entire CNV lesion and extend 100 μm beyond the lesion when the posterior boundary of the CNV is more than 100 μm from the foveal centre.2 Although treatment close to the foveal centre provides the patient with the best chance of avoiding further severe visual loss,2 inadvertent foveal ablation is a complication. To avoid iatrogenic foveolar damage, the exact retinal fixation point must be determined during laser photocoagulation. We designed a new laser treatment apparatus which can determine the exact point continuously during treatment as the patient fixates on the centre of a cross projected onto the fundus.
Materials and methods
The red cross (Fig 1) (4 × 4 mm in length, 0.05 mm in thickness, 0.2 mm between points on the scale) is projected onto the fundus through an apparatus simply attached to the split mirror head of the illumination column of the slit lamp (Zeiss 30 SL in a Nidek ADC-8000S argon/dye laser) (Fig 2). The schematic optical pathway is shown in Figure 3. The red diode laser beam (633 nm) is combined coaxially with the illumination beam to form a cross in the focal plane of the slit lamp. Thus, the cross image is independent of the laser aiming beam. We can adjust the distance between the centre of the target and the laser treatment beam. Images are usually monitored and recorded on an S-VHS video recorder (Sony, SVO-260) through the slit lamp microscope (Fig5). A real image of the cross target on a normal fundus was photographed in 35 mm film for demonstration in Figure1.
We have used this system on 27 patients with juxtafoveal choroidal neovascularisation. The posterior edge of the neovascularisation was within 199 μm from the fixation point.2 Patients' corrected visual acuity ranged from 20/200 to 20/40. Patients were asked which is easier for fixation—the centre of the cross target image or the original laser aiming beam (wavelength is 630 nm). The surgeon monitored the stability of the fixation throughout the laser procedure.
A 45 year old woman underwent treatment for juxtafoveal CNV with our system. Her corrected visual acuity was 18/20 in the left eye at the initial examination. Ophthalmoscopy and fluorescein angiography (Fig 4) revealed juxtafoveal CNV in the left myopic fundus (refractive error −8.5 dioptres). Her vision decreased to 20/40 during the following month because the CNV enlarged. After a full explanation of the advantages and disadvantages of the laser treatment, including foveal damage or late scar expansion, the patient chose to undergo treatment. Using the real time monitoring system, dye laser (wavelength 590 nm) photocoagulation was applied to the juxtafoveal lesion in her left eye (power, 250 mW; size, 150–200 μm; and duration, 0.2 second) (Fig 5). Her fixation point remained stable throughout the laser treatment as she fixated on the centre of the cross. The scale of the cross target was also useful for determining the distance between the edge of the CNV and the laser spot. In this case, her fixation point was approximately 100 μm from the edge of the photocoagulated juxtafoveal lesion. A fundus photograph taken immediately after photocoagulation shows a whitish laser burn close to the foveola (Fig6). No damage to the foveola occurred because her corrected visual acuity improved to 20/20 as a result of the resolution of the serous retinal detachment around the CNV 2 weeks after laser treatment. Ten months later her vision remained the same.
Thirteen (48%) of 27 patients answered that it was easier to keep the focus on the cross target image rather than on the aiming beam. The rest of the patients said that both were about equal. Fixation could be maintained throughout the procedure. The laser treatment was completed without foveal damage near the fixation point in all patients. The cross target image was very useful for the treatment of patients with foveolar subretinal haemorrhage because of disturbed foveal sensitivity.
A technique commonly used to determine the fixation point is by examining fundus photographs and fluorescein angiograms to locate the centre of the foveal avascular zone as the anatomical landmark.3 However, this is not foolproof in eyes in which the macula is affected, because there can be slight variation in fixation away from the centre of the foveal avascular zone.3 Scanning laser ophthalmoscopic microperimetry is a sensitive tool for detecting the fixation point.4 Although the results using microperimetry were helpful for determining the fixation point and the CNV margin,5 6 the location of the centre of fixation cannot be projected in real time onto the fundus during laser treatment.
At present, the only technique to detect the fixation point in real time is to ask the patient to look at the laser aiming beam. This method, however, is sometimes unstable and unreliable especially in patients with disturbed central vision. Moreover, at the time of aiming and photocoagulation, the aiming beam should be moved from the fixation point to the affected lesion to be treated.
In contrast, our novel system provides continuous monitoring of the fixation point during laser photocoagulation. Surgeons can determine the fixation point precisely not only by the anatomical landmark evaluated on fluorescein angiograms but also by real time monitoring of the functional fovea. Because 100 μm corresponds to half of the scale of the cross in our system, surgeons can avoid accidental burns to the foveola even when treating lesions less than 100 μm from the fixation points. We believe that laser photocoagulation to treat juxtafoveal lesions can be more accurately and safely performed using this system because of the patient's stable fixation and the continuous transmission of real time information to the surgeon about the fixation point.